TY - JOUR
T1 - Neuroelectronics and biooptics
T2 - Closed-loop technologies in neurological disorders
AU - Krook-Magnuson, Esther
AU - Gelinas, Jennifer N.
AU - Soltesz, Ivan
AU - Buzsáki, György
N1 - Publisher Copyright:
Copyright 2015 American Medical Association. All rights reserved.
PY - 2015/7/1
Y1 - 2015/7/1
N2 - Brain-implanted devices are no longer a futuristic idea. Traditionally, therapies for most neurological disorders are adjusted based on changes in clinical symptoms and diagnostic measures observed over time. These therapies are commonly pharmacological or surgical, requiring continuous or irreversible treatment regimens that cannot respond rapidly to fluctuations of symptoms or isolated episodes of dysfunction. In contrast, closed-loop systems provide intervention only when needed by detecting abnormal neurological signals and modulating them with instantaneous feedback. Closed-loop systems have been applied to several neurological conditions (most notably epilepsy and movement disorders), but widespread use is limited by conceptual and technical challenges. Herein, we discuss how advances in experimental closed-loop systems hold promise for improved clinical benefit in patients with neurological disorders.
AB - Brain-implanted devices are no longer a futuristic idea. Traditionally, therapies for most neurological disorders are adjusted based on changes in clinical symptoms and diagnostic measures observed over time. These therapies are commonly pharmacological or surgical, requiring continuous or irreversible treatment regimens that cannot respond rapidly to fluctuations of symptoms or isolated episodes of dysfunction. In contrast, closed-loop systems provide intervention only when needed by detecting abnormal neurological signals and modulating them with instantaneous feedback. Closed-loop systems have been applied to several neurological conditions (most notably epilepsy and movement disorders), but widespread use is limited by conceptual and technical challenges. Herein, we discuss how advances in experimental closed-loop systems hold promise for improved clinical benefit in patients with neurological disorders.
UR - http://www.scopus.com/inward/record.url?scp=84937560827&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84937560827&partnerID=8YFLogxK
U2 - 10.1001/jamaneurol.2015.0608
DO - 10.1001/jamaneurol.2015.0608
M3 - Review article
C2 - 25961887
AN - SCOPUS:84937560827
SN - 2168-6149
VL - 72
SP - 823
EP - 829
JO - JAMA Neurology
JF - JAMA Neurology
IS - 7
ER -